MARKET

TLSI

TLSI

TriSalus Life Sciences Inc.
NASDAQ
3.590
-0.070
-1.91%
After Hours: 3.590 0 0.00% 19:30 10/23 EDT
OPEN
3.600
PREV CLOSE
3.660
HIGH
3.720
LOW
3.570
VOLUME
78.40K
TURNOVER
--
52 WEEK HIGH
7.95
52 WEEK LOW
2.200
MARKET CAP
221.05M
P/E (TTM)
-2.7739
1D
5D
1M
3M
1Y
5Y
1D
Press Release: TriSalus Life Sciences to Host Third Quarter 2026 Financial Results Conference Call
Dow Jones · 3d ago
Weekly Report: what happened at TLSI last week (1012-1016)?
Weekly Report · 5d ago
Full Transcript: TriSalus Life Sciences Q2 2026 Earnings Call
Benzinga · 10/12 09:38
Weekly Report: what happened at TLSI last week (1005-1009)?
Weekly Report · 10/12 09:33
Weekly Report: what happened at TLSI last week (0928-1002)?
Weekly Report · 10/05 09:33
Two new option listings on October 1st
TipRanks · 10/01 12:36
H.C. Wainwright Keeps Their Buy Rating on TriSalus Life Sciences (TLSI)
TipRanks · 10/01 10:35
Weekly Report: what happened at TLSI last week (0921-0925)?
Weekly Report · 09/28 09:31
More
About TLSI
TriSalus Life Sciences, Inc. is an oncology-focused medical technology company. It is seeking to transform outcomes for patients with solid tumors by integrating its delivery technology with standard-of-care therapies, and with its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 agonist, for a range of different therapeutic and technological applications. Its delivery method, Pressure-Enabled Drug Delivery (PEDD), modulates pressure and flow within blood vessels to improve intravascular therapeutic delivery into tumors, thereby increasing the likelihood of tumor response in comparison to conventional delivery technologies. Its on-market TriNav Infusion System using PEDD technology, is being used for interventional radiology procedures, commonly transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or in patients with liver metastases. TriNav is a device with a novel (PEDD) delivery method.

Webull offers TriSalus Life Sciences Inc stock information, including NASDAQ: TLSI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLSI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TLSI stock methods without spending real money on the virtual paper trading platform.